Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIIOngoingD-0556-2024

Drug recall · June 26, 2024

Eptifibatide injection 20mg/10mL recall

Why: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Lots / codes

Lot #: 3EF22003, Exp 6/30/2025

Quantity
15,500 single dose vials
Company
Eugia US LLC, East Windsor, NJ
Distribution
USA nationwide.
Initiated
May 22, 2024 · Voluntary: Firm initiated
Classified
June 14, 2024
Reported
June 26, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Eptifibatide

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.